Difference between revisions of "Clarithromycin (Biaxin)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
m |
||
| Line 3: | Line 3: | ||
==Diseases for which it is used== | ==Diseases for which it is used== | ||
| + | *[[Marginal zone lymphoma]] | ||
*[[Multiple myeloma]] | *[[Multiple myeloma]] | ||
| Line 9: | Line 10: | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
| + | [[Category:Oral medications]] | ||
[[Category:Antibacterials]] | [[Category:Antibacterials]] | ||
| + | [[Category:Marginal zone lymphoma medications]] | ||
[[Category:Multiple myeloma medications]] | [[Category:Multiple myeloma medications]] | ||
[[Category:FDA approved in 1991]] | [[Category:FDA approved in 1991]] | ||
Revision as of 02:15, 23 August 2018
Mechanism of action
Antibiotic which inhibits bacterial protein synthesis through binding to the 50S subunit. Mechanism for observed antineoplastic effect may be through suppression of IL-6.
Diseases for which it is used
Also known as
- Brand name: Biaxin